Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Symptoms of circadian desynchronization in patients with multiple sclerosis.]
Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial.
Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis.
Molecular cloning of a human cannabinoid receptor which is also expressed in testis.
Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient.
Teriflunomide (AUBAGIO). Multiple sclerosis: just a metabolite of leflunomide.
Inhibition of glial proliferation, promotion of axonal growth and myelin production by synthetic glycolipid: A new approach for spinal cord injury treatment.
Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.
Alcohol as a Modifiable Lifestyle Factor Affecting Multiple Sclerosis Risk.
Warner Chilcott sells Vectrin product line to Medicis
How to treat tumefactive demyelinating disease?
Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis.
Life-threatening asthma attack during prolonged fingolimod treatment: case report.
Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation.
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients.
Improved operator agreement and efficiency using the minimum area contour change method for delineation of hyperintense multiple sclerosis lesions on FLAIR MRI.
MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination.
Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study.
Personality traits of patients with multiple sclerosis and their relationship with clinical characteristics.
Developing a community multiple sclerosis nursing service.
Cervical Disk Pathology in Patients With Multiple Sclerosis: Two Case Reports.
18F-FDG PET Detects Inflammatory Infiltrates in Spinal Cord Experimental Autoimmune Encephalomyelitis Lesions.
Pages
« first
‹ previous
…
222
223
224
225
226
227
228
229
230
…
next ›
last »